<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04003987</url>
  </required_header>
  <id_info>
    <org_study_id>1903977303</org_study_id>
    <nct_id>NCT04003987</nct_id>
  </id_info>
  <brief_title>ESP Block VS TAP in Laparoscopic Hysterectomy</brief_title>
  <official_title>Erector Spinae Plane Block Versus Transverse Abdominis Plane Block in Laparoscopic Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the difference between two different pain control
      methods in patients who will be having a hysterectomy surgery. By collecting this data, we
      aim to show improved postoperative pain scores, decreased opioid needs, and decreased opioid
      side effects (nausea, sedation, ileus, urinary retention, respiratory depression).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the TAP block, the ultrasound probe is placed transverse to the abdominal wall, between
      the iliac crest and the costal margin. The needle is placed in the plane of the probe and
      advanced until it is between the internal oblique and the transversus abdominis muscles. Once
      in the plane, 2 mL of saline is injected to confirm needle position, then the local
      anesthetic solution is injected. [10]

      For the ESP block, as mentioned previously, the ultrasound is positioned in a parasagittal
      fashion, 2-3 inches lateral to the spinous process. This approach visualizes the transverse
      process. The needle is inserted cranial-to-caudal to make contact with the shadow of the
      transverse process, with the needle tip deep to the fascial plane of the erector spinae
      muscle. Injection of saline confirms the location of the needle, and the anesthetic is
      injected.

      All patients will receive PO acetaminophen and PO gabapentin the morning of surgery. Pt. will
      be placed on PRN oxycodone/acetaminophen (Percocet) postoperatively. PRN IV dilaudid may be
      given for severe breakthrough pain.

      Opioid usage at 1, 24 and 48 hours after the block will be recorded by a member of the
      research team. Pain scores at rest and on movement will be measured by the investigator using
      Visual Analog Scale (VAS). Nausea will be measured using a categorical scoring system
      (none=0; mild=1; moderate=2; severe=3). Sedation scores will also be assessed by a member of
      the study team using a sedation scale (awake and alert=0; quietly awake=1; asleep but easily
      roused=2; deep sleep=3). All these parameters will be measured at 1, 24 and 48 hours after
      the blocks and patients will be encouraged to ambulate on postoperative day 1 under
      supervision. Their ambulation activity will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>ESP Block Group
TAP Block Group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Both the patients and the research staff doing assessments will be blinded to the randomization</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) pain scores at 1 hour.</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>Visual Analogue Scale (VAS) score taken with both rest and movement is measured as minimal to maximal; higher values mean worse pain (scale 0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) pain scores at 24 hours.</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Visual Analogue Scale (VAS) score taken with both rest and movement measured as minimal to maximal; higher values mean worse pain (scale 0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) pain scores at 48 hours.</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Visual Analogue Scale (VAS) score taken with both rest and movement measured as minimal to maximal; higher values mean worse pain(scale 0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient sedation score at 1 hour</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>Sedation is measured as minimum to maximum awareness/level of consciousness; higher values means worse or less awareness (awake, asleep but arousable, deep sleep)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sedation score at 24 hours</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Sedation is measured as minimum to maximum aware ness/level of consciousness: higher values means worse or less awareness (awake, asleep but arousable, deep sleep)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient sedation score at 48 hours</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Sedation is measured as minimum to maximum awareness/level of consciousness; higher values means worse or less awareness (awake, asleep but arousable, deep sleep)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient nausea score at 1 hour</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>Nausea is measured as minimum to maximum: higher values is worse (none, mild, moderate, severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient nausea score at 24 hour</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>Nausea is measured as minimum to maximum: higher values is worse (none, mild, moderate, severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient nausea score at 48 hour</measure>
    <time_frame>48 hour after surgery</time_frame>
    <description>Nausea is measured as minimum to maximum: higher values is worse (none, mild, moderate, severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score at 24 hours</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>patient satisfaction is measured as minimum to maximum; the higher the score the better satisfied (very unsatisfied, unsatisfied, neutral, satisfied, very satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score at 48 hours</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>patient satisfaction is measured as minimum to maximum; the higher the score the better satisfied (very unsatisfied, unsatisfied, neutral, satisfied, very satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>ESP Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the ESP block the ultrasound is positioned in a parasagittal fashion, 2-3 inches lateral to the spinous process. This approach visualizes the transverse process. The needle is inserted cranial-to-caudal to make contact with the shadow of the transverse process, with the needle tip deep to the fascial plane of the erector spinae muscle. Injection of saline confirms the location of the needle, and the anesthetic is injected (40 ml into each side; 20 ml injected at T8 and 20 ml injected at T12)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For the TAP block, the ultrasound probe is placed transverse to the abdominal wall, between the iliac crest and the costal margin. The needle is placed in the plane of the probe and advanced until it is between the internal oblique and the transversus abdominis muscles. Once in the plane, 2 mL of saline is injected to confirm needle position, then the local anesthetic solution is injected (40 ml into each side; 20 ml injected for subcostal TAP and 20 ml injected for posterior TAP).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal bupivacaine</intervention_name>
    <description>20ml</description>
    <arm_group_label>ESP Block</arm_group_label>
    <arm_group_label>TAP Block</arm_group_label>
    <other_name>Exparel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine, 0.125%</intervention_name>
    <description>60ml</description>
    <arm_group_label>ESP Block</arm_group_label>
    <arm_group_label>TAP Block</arm_group_label>
    <other_name>bupivacaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing laparoscopic hysterectomy surgery at Indiana University Hospital

          -  ASA class 1, 2, 3 or 4

          -  Age 18 or older, female

          -  Desires Regional anesthesia for postoperative pain control

        Exclusion Criteria:

          -  History of substance abuse in the past 6 months.

          -  Patients on more than 30 mg morphine equivalents of opioids.

          -  Any physical, mental or medical conditions which in the opinion of the investigators,
             may confound quantifying postoperative pain resulting from surgery.

          -  Known allergy or other contraindications to the study medications (Acetaminophen,
             Gabapentin, Bupivacaine).

          -  Postoperative intubation.

          -  Any BMI greater than 40.0.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yar Yeap, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew Warner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lyla Farlow, LPN</last_name>
    <phone>317-948-9804</phone>
    <email>lychrist@iupui.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angie Plummer, LPN</last_name>
    <phone>317-944-7239</phone>
    <email>plummera@iupui.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana Univeristy</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyla Farlow, LPN</last_name>
      <phone>317-984-9804</phone>
      <email>lychrist@iupui.edu</email>
    </contact>
    <contact_backup>
      <last_name>Angie Plummer, LPN</last_name>
      <phone>317-944-7239</phone>
      <email>plummera@iupui.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lyla Farlow, LPN</last_name>
      <phone>317-948-9804</phone>
      <email>lychrist@iupui.edu</email>
    </contact>
    <contact_backup>
      <last_name>Angie Plummer, LPN</last_name>
      <phone>317-944-7239</phone>
      <email>[lummer@iupui.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Yar Yeap, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Weber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Shaffer EE, Pham A, Woldman RL, Spiegelman A, Strassels SA, Wan GJ, Zimmerman T. Estimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs. Adv Ther. 2017 Jan;33(12):2211-2228. Epub 2016 Nov 9.</citation>
    <PMID>27830448</PMID>
  </results_reference>
  <results_reference>
    <citation>Routman HD, Israel LR, Moor MA, Boltuch AD. Local injection of liposomal bupivacaine combined with intravenous dexamethasone reduces postoperative pain and hospital stay after shoulder arthroplasty. J Shoulder Elbow Surg. 2017 Apr;26(4):641-647. doi: 10.1016/j.jse.2016.09.033. Epub 2016 Nov 15.</citation>
    <PMID>27856266</PMID>
  </results_reference>
  <results_reference>
    <citation>Bacal V, Rana U, McIsaac DI, Chen I. Transversus Abdominis Plane Block for Post Hysterectomy Pain: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2019 Jan;26(1):40-52. doi: 10.1016/j.jmig.2018.04.020. Epub 2018 Apr 30.</citation>
    <PMID>29723644</PMID>
  </results_reference>
  <results_reference>
    <citation>Tsui BCH, Fonseca A, Munshey F, McFadyen G, Caruso TJ. The erector spinae plane (ESP) block: A pooled review of 242 cases. J Clin Anesth. 2019 Mar;53:29-34. doi: 10.1016/j.jclinane.2018.09.036. Epub 2018 Oct 3. Review.</citation>
    <PMID>30292068</PMID>
  </results_reference>
  <results_reference>
    <citation>Petsas D, Pogiatzi V, Galatidis T, Drogouti M, Sofianou I, Michail A, Chatzis I, Donas G. Erector spinae plane block for postoperative analgesia in laparoscopic cholecystectomy: a case report. J Pain Res. 2018 Sep 24;11:1983-1990. doi: 10.2147/JPR.S164489. eCollection 2018.</citation>
    <PMID>30288093</PMID>
  </results_reference>
  <results_reference>
    <citation>Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.</citation>
    <PMID>27501016</PMID>
  </results_reference>
  <results_reference>
    <citation>Vyas KS, Rajendran S, Morrison SD, Shakir A, Mardini S, Lemaine V, Nahabedian MY, Baker SB, Rinker BD, Vasconez HC. Systematic Review of Liposomal Bupivacaine (Exparel) for Postoperative Analgesia. Plast Reconstr Surg. 2016 Oct;138(4):748e-56e. doi: 10.1097/PRS.0000000000002547. Review.</citation>
    <PMID>27673545</PMID>
  </results_reference>
  <results_reference>
    <citation>Hadzic A, Minkowitz HS, Melson TI, Berkowitz R, Uskova A, Ringold F, Lookabaugh J, Ilfeld BM. Liposome Bupivacaine Femoral Nerve Block for Postsurgical Analgesia after Total Knee Arthroplasty. Anesthesiology. 2016 Jun;124(6):1372-83. doi: 10.1097/ALN.0000000000001117.</citation>
    <PMID>27035853</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu ZQ, Min JK, Wang D, Yuan YJ, Li H. Liposome bupivacaine for pain control after total knee arthroplasty: a meta-analysis. J Orthop Surg Res. 2016 Jul 22;11(1):84. doi: 10.1186/s13018-016-0420-z.</citation>
    <PMID>27443874</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 23, 2019</study_first_submitted>
  <study_first_submitted_qc>June 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2019</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Yar Yeap</investigator_full_name>
    <investigator_title>Director, Acute Pain Service Assistant Professor of Clinical Anesthesiololgy Department of Anesthesiology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

